CellSource Co., Ltd.
4880.T · JPX
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥4 | ¥4 | ¥5 | ¥4 |
| % Growth | -14.8% | -3.4% | 5.5% | – |
| Cost of Goods Sold | ¥2 | ¥2 | ¥1 | ¥1 |
| Gross Profit | ¥2 | ¥2 | ¥3 | ¥3 |
| % Margin | 56.2% | 55.5% | 70.6% | 71.7% |
| R&D Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥2 | ¥0 | ¥0 | ¥0 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥2 | ¥1 | ¥1 |
| Operating Expenses | ¥2 | ¥2 | ¥2 | ¥1 |
| Operating Income | ¥0 | ¥0 | ¥1 | ¥2 |
| % Margin | 4.5% | 3% | 27.1% | 36.8% |
| Other Income/Exp. Net | -¥0 | ¥0 | ¥0 | ¥0 |
| Pre-Tax Income | ¥0 | ¥0 | ¥1 | ¥2 |
| Tax Expense | ¥0 | ¥0 | ¥0 | ¥1 |
| Net Income | ¥0 | ¥0 | ¥1 | ¥1 |
| % Margin | 0.3% | 5.5% | 20.5% | 23.8% |
| EPS | 0.54 | 12.01 | 48.88 | 54.54 |
| % Growth | -95.5% | -75.4% | -10.4% | – |
| EPS Diluted | 0.54 | 11.96 | 47.93 | 52.98 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥0 | ¥0 | ¥0 | ¥0 |
| EBITDA | ¥0 | ¥0 | ¥1 | ¥2 |
| % Margin | 8.5% | 10.3% | 29% | 38.5% |